1,106 material Form 8-K filings that 909 companies we cover made with the SEC in June 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Diversified Healthcare Trust posted an investor presentation on June 1, 2026 that raises its full-year 2026 guidance. Normalized FFO per common share is now expected at $0.56 to $0.62, up from $0.52 to $0.58, and the company attributes the $10 million midpoint increase in SHOP NOI to expense savings in dietary and labor costs.
Normalized FFO per common share guidance rose to $0.56-$0.62 from $0.52-$0.58, a $0.04 increase at the midpoint.
Normalized FFO guidance is $135 million-$150 million, up from $125 million-$140 million; Adjusted EBITDAre guidance is $300 million-$315 million, up from $290 million-$305 million.
SHOP NOI guidance rose to $185 million-$195 million from $175 million-$185 million, driven by targeted cost initiatives, primarily across dietary and labor.
Moody's upgraded the company to B3 in April 2026 and revised its ratings outlook from stable to positive.
SAIC reported first-quarter fiscal 2027 revenue of $1.91 billion, up about 2%, with net income of $115 million, up from $68 million a year earlier. The company raised its adjusted EBITDA and adjusted diluted EPS guidance for fiscal 2027 and reiterated its revenue and free cash flow guidance, which matters to shareholders because the higher profit outlook points to stronger expected earnings, though the quarter included a $12 million gain from an investment sale.
Revenues were $1.91 billion, up 2% from $1.88 billion; organic growth was about 0.5% after adjusting for the SilverEdge acquisition, which added $19 million.
Diluted EPS was $2.61 versus $1.42 a year earlier; adjusted diluted EPS was $3.23 versus $1.92.
Adjusted diluted EPS guidance was raised to $9.90 to $10.10 from $9.50 to $9.70; adjusted EBITDA guidance was raised to $720 million to $730 million from $705 million to $715 million.
The Board declared a quarterly dividend of $0.37 per share, payable July 24, 2026 to holders of record on July 10, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.